Norepinephrine (NE) uptake and NE receptor mechanisms play important modulating roles in the discriminative stimulus and stimulant effects of cocaine. The present study investigated the role of NE mechanisms in cocaine priming-induced reinstatement of extinguished drug seeking.
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Introduction laboratory animals, providing potentially useful models for investigating the biological basis of relapse (Spealman et al., 2004; Bossert et al., 2005) . The strongest evidence for a role for the noradrenergic system in cocaine relapse comes from studies of stress-induced reinstatement of drug-seeking. For example, the α2-adrenoceptor antagonists yohimbine and RS-79948 can reinstate cocaine-seeking behavior in monkeys at doses that induce physiological and behavioral indicators of stress (Lee et al., 2004) . Moreover, the priming effects of yohimbine can be reversed with the α2-adrenoceptor agonist clonidine (Lee et al., 2004) . Clonidine and other α2-agonists also have been shown to inhibit footshock-induced reinstatement of cocaine seeking in rats (Erb et al., 2000) . Beta adrenergic mechanisms also may play a role in stressinduced reinstatement as central administration of β1-and β2-adrenoceptor antagonists block footshock-induced reinstatement of cocaine-seeking (Leri et al., 2002) .
The purpose of the present study was to investigate the role of NE mechanisms in cocaine priming-induced reinstatement in monkeys by evaluating the ability of the selective NE transport inhibitors talsupram and nisoxetine to mimic or modulate the relapse-inducing effects of cocaine and the cocaine-like priming effects of GBR 12909, a selective DA transport inhibitor.
Additional studies were conducted to assess the role of specific subtypes of adrenergic receptors in cocaine priming-induced reinstatement by investigating the degree to which selective α1-and β-adrenoceptor antagonists (prazosin and propranolol, respectively) and a selective α2-adrenoceptor agonist (clonidine) attenuated reinstatement of drug seeking induced by nisoxetine, GBR 12909 and cocaine priming. Finally, the ability of nisoxetine and cocaine to engender physiological and behavioral indices of stress was evaluated in an additional group of monkeys. Understanding the neurobiological mechanisms mediating reinstatement of cocaine seeking in animals may aid development of pharmacotherapies to combat relapse to cocaine use in people.
response. Colored lights mounted above the levers could be illuminated to serve as visual stimuli. Catheters were connected to a syringe pump (Med Associates, Inc.; Georgia, VT) located outside of the chamber. Each operation of the pump lasted 1 s and delivered 0.18 ml of vehicle or drug solution into the catheter.
Observational studies followed by saliva collection were conducted in a ventilated, transparent Plexiglas arena (114 cm long X 122 cm wide X 213 cm high) located in a lighted room isolated from other animals. The arena was equipped with perches, suspended plastic chains, and a wood-chip foraging substrate to allow for the expression of a range of speciestypical behaviors. A video camera and a videocassette recorder operated continuously during the observation session.
Cocaine self-administration and extinction. Monkeys were trained to respond under a second-order fixed-interval (FI), fixed-ratio (FR) schedule of reinforcement. In the presence of a white light, completion of every n th response (FR 10 or 30; depending on the monkey) during a 10-min interval of time (FI 10) resulted in a 2-s change in illumination from white to red light.
Completion of the first FR after the 10-min interval elapsed produced both the 2-s light change and an i.v. injection of cocaine. A 60-s timeout period, during which all lights were off and responses had no scheduled consequences, followed each injection. If the FR requirement was not completed within 8 min following the expiration of the FI, the component ended automatically without an injection. Daily sessions ended after five cycles of the second-order schedule. Initially, the dose of cocaine was varied over a 10-fold or greater range to determine the dose that maintained maximum rates of responding for each monkey. The selected cocaine doses were 0.18 or 0.3 mg/kg/injection depending on the particular subject, and these doses of cocaine were kept constant for the remainder of the study.
Following a 6-to 8-month period of stable cocaine self-administration under the secondorder schedule, responding was extinguished by substituting saline for cocaine and omitting all JPET #121806 8 presentations of the 2-s stimulus. Extinction sessions were otherwise identical to those described above for cocaine self-administration. Extinction sessions were conducted daily until response rate declined and stabilized at ≤ 10% of the rate maintained during active cocaine selfadministration (3-10 sessions depending on the subject).
Reinstatement of drug seeking. Tests for priming-induced reinstatement of extinguished cocaine seeking were begun once the criteria for extinction were satisfied.
Reinstatement test sessions used procedures identical to those during cocaine selfadministration except that only saline was available for self-administration. Response contingent presentations of the cocaine-paired stimulus were restored during reinstatement test sessions because earlier studies showed that reinstatement of drug seeking induced by cocaine priming was greatest when priming injections were accompanied by restoration of the cocainepaired stimulus (Spealman et al., 2004) . Between reinstatement test sessions with different doses of a particular drug, extinction sessions were conducted to ensure that monkeys maintained low rates of responding. Between experiments with different drugs, cocaine selfadministration was re-established using the procedures described previously until responding stabilized (defined as no upward or downward trend in response rate across at least three daily self-administration sessions). Depending upon the subject, it took between 3 to 9 sessions to achieve stable self-administration behavior. Previous studies have shown that by periodically re-establishing and then extinguishing drug-seeking behavior, reinstatement of drug seeking can be reliably induced by cocaine priming over several years of testing.
To evaluate their capacity to reinstate cocaine-seeking behavior, tests were conducted with saline and a range of doses of cocaine (0.1 -1 mg/kg), the selective DA transport inhibitor GBR 12909 (0.3 -1.8 mg/kg), and the selective NE transport inhibitors nisoxetine (0.3 -3 mg/kg) and talsupram (1 -5.6 mg/kg). Drugs were administered i.v. immediately before the session and followed by a saline flush to clear the catheter of residual drug solution. Different
This article has not been copyedited and formatted. The final version may differ from this version. Scoring of videotapes was conducted by two observers who were trained in the use of the behavioral scoring system described in Lee et al. (2004) , but were not informed about the drugs under investigation. Before beginning the study, each observer underwent at least 20 h of training until they reached an interobserver reliability criterion of ≥ 90% based on percent agreement scores. The behavioral scoring system included 10 categories (Table 1) , which were scored by recording the presence or absence of each behavior in 15-s intervals during three 5-min observation periods across the session (0 -5, 7 -12, 24 -29 min) . Frequency scores were calculated from these data as the number of 15-s intervals in which a particular behavior was observed.
In addition, during the 6 th , 18 th , and 30 th min of each session, the monkey was removed from the observational arena by a trained handler and evaluated for ataxia [defined as the inability to balance on and/or grasp a stainless steel pole (56 cm in length; 1 cm in diameter) held in a horizontal plane] and muscle resistance (defined as resistance to hind limb extension).
For ataxia, a score of 0 indicated that the monkey was able to balance normally on the pole, a score of 1 indicated inability to balance effectively, and a score of 2 indicated that the monkey could neither balance on nor grasp the pole. For muscle resistance, a score of 0 indicated no change in resistance to hind limb extension, a score of +1 indicated increased resistance to extension and/or clinging to the grid floor, and a score of -1 indicated decreased resistance to extension and/or flaccidity.
This article has not been copyedited and formatted. The final version may differ from this version. and saline vehicle on circulating levels of cortisol, a physiological stress marker, were measured in saliva pre-and 90 min post-injection. A comparable study with cocaine was conducted in the context of an earlier experiment (Lee et al., 2003) . Saliva was collected noninvasively in the observation arena between 0830 and noon using the techniques described in Lee et al. (2004) .
Briefly, a device consisting of a PVC pole with a dried cotton dental rope (3/8 in diameter, 5 cm long, Richmond Dental, Charlotte, NC) flavored with concentrated Kool-Aid solution was given to a monkey. After the monkey chewed and dampened the dental rope with saliva, the device was retrieved, and the dental rope was placed in a salivette tube (Sarstedt, Germany). The saliva was extracted by centrifugation at 1000 rpm for 12 min and frozen at -80°C for later cortisol assay. Cortisol levels in saliva were determined in duplicate using a commercially available radioimmunoassay kit (Diagnostic Products Corporation, CA). The intra-assay coefficient of variation for cortisol was 3.9%. In the observation study, for each drug, individual scores for each behavior were averaged over the three 5-min observation periods because no systematic trends were observed across the three observation periods of the test session (as determined by separate repeated measures ANOVAs). Scores were then averaged across subjects to provide group means. Group means for each behavior were analyzed with separate one-way or two-way repeated measures ANOVAs followed by Bonferroni t-tests as appropriate. The effect of nisoxetine on salivary cortisol levels was assessed with a one-way repeated measures ANOVA.
The alpha level for all statistical tests was p ≤ 0.05. Priming effects of selective DA and NE transport inhibitors. Priming with the DA transport inhibitor GBR 12909 induced dose-dependent reinstatement of cocaine-seeking behavior (Fig. 1b) . Doses of 1 and 1.8 mg/kg GBR 12909 engendered significant increases in response rates compared to rates following a vehicle prime [F(3,20) = 13.7, p < 0.001, Bonferroni t-tests]. Average response rates produced by high doses of GBR 12909 were comparable to those induced by a maximally effective priming dose of cocaine.
Drugs. (-)-
The NE transport inhibitors nisoxetine and talsupram also reinstated extinguished cocaine seeking ( Fig. 1c and 1d , respectively). Priming injections of the highest doses of nisoxetine (3 mg/kg) and talsupram (5.6 mg/kg) engendered significantly higher response rates than rates observed following a vehicle prime [nisoxetine: F(3,20) = 4.9, p < 0.01, talsupram:
This article has not been copyedited and formatted. The final version may differ from this version. Interactions between cocaine and selective DA and NE transport inhibitors.
Pretreatment with a maximally effective dose of GBR 12909 (1 mg/kg) prior to cocaine priming resulted in an augmentation of drug-seeking behavior (Fig. 2a) . Specifically, combinations of GBR 12909 with a low, ineffective priming dose of cocaine (0.1 mg/kg) engendered significantly higher response rates compared to cocaine alone (p < 0.05, Bonferroni t-tests). GBR 12909 did not significantly increase the rate of reinstated cocaine seeking induced by a maximally effective priming dose of cocaine (1 mg/kg).
When maximally effective doses of nisoxetine (3 mg/kg) or talsupram (5.6 mg/kg) were administered as pretreatments before cocaine priming, a similar pattern of effects was observed ( Fig. 2b and 2c , respectively). Combination of either NE uptake inhibitor with a normally ineffective dose of cocaine (0.1 mg/kg) resulted in a significant increase in drug seeking (p < 0.05, Bonferroni t-tests) compared to cocaine alone. As in the case of GBR 12909, combining nisoxetine and talsupram with the maximally effective dose of cocaine (1 mg/kg) did not significantly increase the rate of responding.
Interactions between GBR 12909 and selective NE transport inhibitors. In contrast to the effects observed when either nisoxetine or talsupram was combined with cocaine, pretreatment with maximally effective doses of nisoxetine (3 mg/kg) and talsupram (5.6 mg/kg) did not reliably alter reinstatement induced by either a low or high dose of GBR 12909 ( Fig. 3a and 3b, respectively). In no case was the effect of the combination of the NE uptake inhibitors and GBR 12909 greater than the sum of the individual drug effects. The opposite pattern of effects was observed when a range of doses of the α1-adrenoceptor antagonist prazosin was administered as a pretreatment before priming with GBR 12909 or nisoxetine (Fig. 4b) . That is, the cocaine-like priming effects of nisoxetine, but not Pretreatment with the α2-adrenoceptor agonist clonidine also produced dose-dependent reductions in the priming effects of nisoxetine, but not GBR 12909 (Fig. 4c) Finally, pretreatment with the β-adrenoceptor antagonist propranolol produced effects similar to those of the α-adrenoceptor ligands. Propranolol reliably reduced the cocaine-like priming effects of nisoxetine, but not GBR 12909 (Fig. 4d) . Effects of nisoxetine and cocaine on observed behavior and salivary cortisol levels. Nisoxetine had no significant effects on observed behavior over the range of doses that reinstated cocaine-seeking behavior (Table 2) . Nisoxetine (0.3 -3 mg/kg) neither increased nor decreased locomotion, object exploration, foraging, visual scanning, or vocalization compared to levels observed during saline control sessions. It also did not induce a significant change in rest posture, static posture, balance, or muscle resistance. Importantly, no dose of nisoxetine induced behavioral signs of stress (i.e., increased self-directed grooming and scratching, 2). Moreover, compared to vehicle control levels, no dose of nisoxetine significantly increased salivary cortisol levels, a physiological marker of stress.
Similarly, cocaine had few significant effects on observed behavior. Cocaine (0.1 -1 mg/kg) did not alter measures of locomotion, object exploration, foraging, visual scanning, vocalization, rest posture, static posture, balance, or muscle resistance. Cocaine did, however, reliably decrease measures of self-directed behavior (Table 2) . That is, all doses of cocaine reduced scratching levels [F(3,9) = 8.5, p < 0.005; Bonferroni t-test] and the two highest cocaine doses eliminated self-grooming [F(3,9) = 4.6, p < 0.032; Bonferroni t-test]. These effects are opposite of what has been shown for yohimbine, a pharmacological stressor (cf. Lee et al., 2004) . Salivary cortisol data for cocaine were obtained from Lee et al. (2003) and show that, like nisoxetine, cocaine (0.3 and 1 mg/kg) had no reliable effect on salivary cortisol levels.
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Discussion
DA mechanisms undoubtedly play a critical role in the effects of cocaine related to its abuse. Less is known, however, regarding the role of NE mechanisms in cocaine's behavioral effects. In this study, priming injections of the NE transport inhibitors nisoxetine and talsupram engendered reliable reinstatement of cocaine-seeking behavior, although not to the same degree as the DA transport inhibitor GBR 12909 or cocaine itself. Maximally effective doses of cocaine and GBR 12909 engendered response rates comparable to those observed during active cocaine self-administration, whereas the NE transport inhibitors engendered rates approximately half those engendered by cocaine. In drug combination studies, nisoxetine and talsupram augmented the priming effects of cocaine. These findings support the idea that inhibition of DA uptake plays a key role in the priming effects of cocaine and also are consistent with the hypothesis that NE uptake inhibition can contribute to these effects of cocaine.
Our results supporting a role for NE mechanisms in the priming effects of cocaine differ from the majority of data reported in rats, which show little role for these mechanisms in the behavioral effects of cocaine, including its reinstatement-inducing effects (Schmidt and Pierce, 2006) . These dissimilar findings may reflect underlying species differences in the NE system of primates compared to rodents. For example, Paczkowski et al. (1999) showed quantitative differences in the pharmacological profiles for human and rat NE transporters including an increased affinity for cocaine for the human transporter compared to the rat transporter. In addition, the distribution of NE transporters in nonhuman primate brain has been shown to differ in some significant respects from the distribution in rats (Smith et al., 2006) . Along with studies that show significant upregulation of NE transporters as a consequence of long-term cocaine exposure in monkeys (Macey et al., 2003; Beveridge et al., 2005) but not rats (Belej et al., 1996; Arroyo et al., 2000) , these findings provide a basis for the speculation that NE uptake inhibition plays a more important role in the priming effects of cocaine in primates compared to rodents.
This article has not been copyedited and formatted. The final version may differ from this version. It has been suggested that shared discriminative stimulus effects may contribute to the degree to which a drug can reinstate cocaine-seeking behavior (see Katz and Higgins, 2003; Shaham et al., 2003 for reviews) . Indeed, in addition to reinstating cocaine seeking, NE transport inhibitors share discriminative stimulus effects with cocaine (Cunningham and Callahan, 1991; Baker et al., 1993; Johanson and Barrett, 1993; Terry et al., 1994; Spealman, 1995) . Cocaine also induces cardiovascular effects (e.g., increases in heart rate, diastolic and systolic blood pressure; Tella et al., 1993 ) that mimic those of some NE transport inhibitors, including nisoxetine, raising the possibility that common peripheral effects might contribute to a discriminable cue. However, the discriminative stimulus, as well as cardiovascular effects, of cocaine can be attenuated by antagonists with selectivity for α1 adrenoceptors only or in addition to β adrenoceptors (Johanson and Barrett, 1993; Sofuoglu et al., 2000a; 2000b; Spealman, 1995) . Although the cocaine-like priming effects of nisoxetine were attenuated by both prazosin (selective for α1 adrenoceptors) and propranolol (selective for β adrenoceptors) in the present study, the priming effects of cocaine itself were not, suggesting that common discriminable cues (whether peripheral or central) do not underlie the ability of NE transport inhibitors to reinstate cocaine seeking.
Both nisoxetine and talsupram are selective for NE transporters compared to DA transporters (~50-to >1000-fold selective, respectively; e.g., Czoty et al., 2004; McConathy et al., 2004) . However, for nisoxetine at least, its affinity for the DA transporter is within the range of that of GBR 12909 and other drugs that share behavioral effects with methamphetamine, a stimulant whose effects are prominently mediated by dopaminergic mechanisms (e.g., Czoty et al., 2004) . The latter finding raises the possibility that the ability of NE transport inhibitors to partially mimic the priming effects of cocaine is due to their ability to increase DA directly via interactions with the DA transporter. However, the priming effects of nisoxetine were not attenuated by dopamine receptor-selective doses of the antagonist flupenthixol suggesting that Alternatively, the cocaine-like priming effects of NE transport inhibitors may reflect their capacity to indirectly regulate midbrain DA levels via prefrontal cortical adrenergic receptors.
Stimulant-induced increases in NE transmission in this brain region have been linked to increased DA cell bursting in the ventral tegmental area as well as increased DA release in the nucleus accumbens, critical brain regions mediating drug priming-induced reinstatement (Darracq et al., 1998; Ventura et al., 2003; 2005) . A similar effect on DA cells was observed following intravenous administration of nisoxetine (Shi et al., 2000) . Additional evidence suggests that the increase in DA release observed in the nucleus accumbens is mediated by α1-adrenoceptors in the prefrontal cortex and not DA receptors, as the changes in DA neuron firing and DA release could be attenuated by the α1-adrenoceptor antagonist prazosin but not the DA receptor antagonists SCH 23390 or raclopride (Darracq et al., 1998; Shi et al., 2000) .
Our data are consistent with these neurochemical findings in that the cocaine-like priming effects of nisoxetine could be attenuated by prazosin, but not the DA antagonist flupenthixol. A DA augmenting mechanism also may underlie the ability of nisoxetine and talsupram to increase drug seeking induced by low priming doses of cocaine. The NE transport inhibitors did not, however, enhance the reinstatement of drug seeking induced by GBR 12909, suggesting the possibility that the increase in extracellular DA induced by DA uptake inhibition was sufficient to mask the presumably smaller effects of nisoxetine and talsupram on DA neuron firing.
In antagonism studies, nisoxetine-but not GBR 12909-induced priming also was attenuated by the α2-adrenoceptor agonist clonidine and the β-adrenoceptor antagonist propranolol. Both α2-and β-adrenoceptor mechanisms have been implicated as factors underlying stress-induced reinstatement (Erb et al., 2000; Leri et al., 2002; Lee et al., 2004) . Thus, it is possible that nisoxetine and talsupram induced reinstatement as a consequence of their ability to increase synaptic levels of NE and thereby activate stress pathways in the brain.
The BNST is a brain region that is enriched by NE neurons as well as sensitive to neuroadaptations induced by long-term cocaine exposure (upregulation of NE transporters; Macey et al., 2003; Beveridge et al., 2005) . This region also is critical for autonomic responses to stressors. Heightened noradrenergic tone in this region can stimulate release of corticotropin-releasing factor from the hypothalamus, an important initial response to stress (Koob, 1999; Beveridge et al., 2005) . However, unlike the anxiogenic α2-adrenoceptor antagonist yohimbine, nisoxetine failed to increase either physiological or behavioral indices of stress (Table 2 ; cf. Lee et al., 2004) . The present results provide no evidence to suggest that activation of stress pathways played a major role in the ability of the NE transport inhibitors to reinstate cocaine-seeking behavior.
In antagonism studies with cocaine, flupenthixol and clonidine effectively attenuated priming-induced reinstatement. Our finding that flupenthixol antagonized cocaine's priming effects at a dose that was effective against GBR 12909-induced priming is in agreement with the large body of evidence indicating a primary role for DA receptor mechanisms in cocaineinduced reinstatement (see Bossert et al., 2005 for review). However, clonidine's ability to attenuate cocaine priming was unexpected in light of the finding that clonidine and other α2-adrenoceptor agonists did not alter cocaine priming-induced reinstatement in rats (Erb et al., 2000) . The effect of clonidine in the present study does not appear to be related to potential cocaine-induced activation of brain stress pathways as cocaine neither engendered behavioral signs of stress in observation studies nor increased salivary cortisol levels (Table 2 ; Lee et al., 2003) . It remains a possibility that species differences in the regional distribution, receptor heterogeneity and pharmacological properties of α2-adrenoceptors underlie the differential effects of clonidine in primates versus rats (Zilles et al., 1993; Molderings et al., 2000) .
This article has not been copyedited and formatted. The final version may differ from this version. In contrast to the results with flupenthixol and clonidine, neither prazosin nor propranolol altered cocaine priming-induced reinstatement. These findings were unexpected given the effectiveness of these adrenergic compounds against cocaine in other species and/or procedures. For example, prazosin has been shown to reduce cocaine-induced reinstatement in rats (Zhang and Kosten, 2005) and attenuate the discriminative stimulus effects of cocaine in monkeys (Spealman, 1995) . Likewise, propranolol has been shown to decrease cocaine selfadministration in both rats and monkeys (Goldberg and Gonzalez, 1976; Harris et al., 1996) .
The reasons underlying the divergent effects of prazosin and propranolol in the present study are not clear. Nevertheless, they highlight the fact that diverse receptor mechanisms likely contribute to the different behavioral effects of cocaine. For example, whereas pharmacological inhibition of NE uptake appears to play a role in cocaine priming-induced reinstatement, this mechanism seems to have a less significant impact in the reinforcing effects of cocaine. Along these lines, in rhesus monkeys previously trained to self-administer cocaine, the selective NE transport inhibitors nisoxetine, desipramine and atomoxetine do not maintain self-administration above vehicle levels (Woolverton, 1987; Wee and Woolverton, 2004; Wee et al., 2006) .
Moreover, when combined with cocaine, neither nisoxetine nor desipramine systematically alter cocaine self-administration, even at doses that produce virtually complete inhibition of NE uptake (Tella, 1995; Wee et al., 2005) .
In summary, this study presents evidence of a significant role for NE inhibition and α2-adrenoceptor mechanisms in cocaine-induced reinstatement of drug-seeking. These mechanisms appear not to contribute universally to the behavioral effects of cocaine, but rather are specific to cocaine-induced reinstatement in monkeys. The specificity may reflect underlying neurobiological differences between monkeys and rodents and/or unique mechanisms associated with drug-induced reinstatement versus other behavioral effects including the discriminative stimulus and reinforcing effects of cocaine. This article has not been copyedited and formatted. The final version may differ from this version. 
